- Home
- Publications
- Publication Search
- Publication Details
Title
Tau PET imaging in neurodegenerative tauopathies—still a challenge
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-11
DOI
10.1038/s41380-018-0342-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- [18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive Aphasia
- (2018) Hyon Lee et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease
- (2018) Antoine Leuzy et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- [18 F]AV-1451 tau-PET and primary progressive aphasia
- (2018) Keith A. Josephs et al. ANNALS OF NEUROLOGY
- [18 F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease
- (2018) Jennifer L. Whitwell et al. ANNALS OF NEUROLOGY
- Is longitudinal tau PET ready for use in Alzheimer’s disease clinical trials?
- (2018) Oskar Hansson et al. BRAIN
- Networks of tau distribution in Alzheimer’s disease
- (2018) Merle C Hoenig et al. BRAIN
- Longitudinal tau PET in ageing and Alzheimer’s disease
- (2018) Clifford R Jack et al. BRAIN
- PET imaging of tau protein targets: a methodology perspective
- (2018) Cristina Lois et al. Brain Imaging and Behavior
- First-in-human brain imaging of Alzheimer dementia patients and elderly controls with18F-MK-6240, a PET tracer targeting neurofibrillary tangle pathology
- (2018) Talakad G Lohith et al. JOURNAL OF NUCLEAR MEDICINE
- In vivo characterization and quantification of neurofibrillary tau PET radioligand [18F]MK-6240 in humans from Alzheimer’s disease dementia to young controls
- (2018) Tobey J Betthauser et al. JOURNAL OF NUCLEAR MEDICINE
- The Value of In Vitro Binding as Predictor of In Vivo Results: A Case for [18F]FDDNP PET
- (2018) Graham B. Cole et al. MOLECULAR IMAGING AND BIOLOGY
- Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals
- (2018) Heidi I. L. Jacobs et al. NATURE NEUROSCIENCE
- Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions
- (2018) Victor L. Villemagne et al. Nature Reviews Neurology
- Predicted sequence of cortical tau and amyloid-β deposition in Alzheimer disease spectrum
- (2018) Hanna Cho et al. NEUROBIOLOGY OF AGING
- Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake
- (2018) Sandhitsu R. Das et al. NEUROBIOLOGY OF AGING
- Comparing18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease
- (2018) Niklas Mattsson et al. NEUROLOGY
- Tau Kinetics in Neurons and the Human Central Nervous System
- (2018) Chihiro Sato et al. NEURON
- Unconventional Secretion Mediates the Trans-cellular Spreading of Tau
- (2018) Taxiarchis Katsinelos et al. Cell Reports
- [18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy
- (2018) Matthias Brendel et al. Frontiers in Aging Neuroscience
- Associations Between Tau, β-Amyloid, and Cognition in Parkinson Disease
- (2018) Joseph R. Winer et al. JAMA Neurology
- Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
- (2018) Leonardo Iaccarino et al. NeuroImage-Clinical
- Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
- (2018) Leonie Beyer et al. Frontiers in Neurology
- Large inter- and intra-case variability of first generation tau PET ligand binding in neurodegenerative dementias
- (2018) Melissa C. Wren et al. Acta Neuropathologica Communications
- Neuroimaging-pathological correlations of [18F]THK5351 PET in progressive supranuclear palsy
- (2018) Aiko Ishiki et al. Acta Neuropathologica Communications
- Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807
- (2018) David T. Chien et al. JOURNAL OF ALZHEIMERS DISEASE
- Regional times to equilibria and their impact on semi-quantification of [18F]AV-1451 uptake
- (2018) Kerstin Heurling et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- [18 F]AV-1451 binding and postmortem pathology of CBD
- (2018) Sarah Coakeley et al. MOVEMENT DISORDERS
- Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer’s disease and frontotemporal dementia
- (2017) Young Kyoung Jang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease
- (2017) Jeffrey S. Phillips et al. HUMAN BRAIN MAPPING
- PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
- (2017) Michael S. Rafii et al. JOURNAL OF ALZHEIMERS DISEASE
- Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography
- (2017) Luca C. Gobbi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging
- (2017) Anne Maass et al. JOURNAL OF NEUROSCIENCE
- Preclinical Evaluation of 18 F-JNJ64349311, a Novel PET Tracer for Tau Imaging
- (2017) Lieven Declercq et al. JOURNAL OF NUCLEAR MEDICINE
- Correlations of18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease
- (2017) Ryuichi Harada et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Evaluation of18F-RO6958948,11C-RO6931643, and11C-RO6924963 as Novel PET Radiotracers for Imaging Tau Aggregates in Alzheimer Disease
- (2017) Michael Honer et al. JOURNAL OF NUCLEAR MEDICINE
- Tau PET imaging: present and future directions
- (2017) Laure Saint-Aubert et al. Molecular Neurodegeneration
- The release and trans-synaptic transmission of Tau via exosomes
- (2017) Yipeng Wang et al. Molecular Neurodegeneration
- Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia
- (2017) K Chiotis et al. MOLECULAR PSYCHIATRY
- Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases
- (2017) Seung Ha Lee et al. MOVEMENT DISORDERS
- Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to α-synuclein pathology
- (2017) Shunsuke Koga et al. MOVEMENT DISORDERS
- Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
- (2017) Günter U. Höglinger et al. MOVEMENT DISORDERS
- PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins
- (2017) Alexandra Perez-Soriano et al. MOVEMENT DISORDERS
- The tau positron-emission tomography tracer AV-1451 binds with similar affinities to tau fibrils and monoamine oxidases
- (2017) Céline Vermeiren et al. MOVEMENT DISORDERS
- Cryo-EM structures of tau filaments from Alzheimer’s disease
- (2017) Anthony W. P. Fitzpatrick et al. NATURE
- Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy
- (2017) David R Corey NATURE NEUROSCIENCE
- Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease
- (2017) Hanna Cho et al. NEUROBIOLOGY OF AGING
- Tau positron emission tomography using [ 18 F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease
- (2017) Jae Myeong Kang et al. NEUROBIOLOGY OF AGING
- AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure
- (2017) Shruti Mishra et al. NEUROIMAGE
- Amyloid and tau PET demonstrate region-specific associations in normal older people
- (2017) Samuel N. Lockhart et al. NEUROIMAGE
- Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease
- (2017) Anne Maass et al. NEUROIMAGE
- The association between tau PET and retrospective cortical thinning in clinically normal elderly
- (2017) Molly R. LaPoint et al. NEUROIMAGE
- Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample
- (2017) Renaud La Joie et al. NEUROLOGY
- 18 F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome
- (2017) Hanna Cho et al. NEUROLOGY
- In vivo retention of 18 F-AV-1451 in corticobasal syndrome
- (2017) Ruben Smith et al. NEUROLOGY
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains
- (2017) Laetitia Lemoine et al. Alzheimers Research & Therapy
- Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals
- (2017) Prashanthi Vemuri et al. JAMA Neurology
- Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
- (2017) Chenjie Xia et al. JAMA Neurology
- Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden
- (2017) Rachel F. Buckley et al. JAMA Neurology
- Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case
- (2017) Marta Marquié et al. Acta Neuropathologica Communications
- Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
- (2016) Ruben Smith et al. ACTA NEUROPATHOLOGICA
- [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration
- (2016) Keith A. Josephs et al. ACTA NEUROPATHOLOGICA
- Multimodal evaluation demonstrates in vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration
- (2016) Corey T. McMillan et al. ACTA NEUROPATHOLOGICA
- Characterization of tau positron emission tomography tracer [ 18 F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias
- (2016) Kerstin Sander et al. Alzheimers & Dementia
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
- (2016) Hanna Cho et al. ANNALS OF NEUROLOGY
- Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease
- (2016) Andrei G. Vlassenko et al. ANNALS OF NEUROLOGY
- AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies
- (2016) Kejal Kantarci et al. ANNALS OF NEUROLOGY
- Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology
- (2016) Helen Ling et al. BRAIN
- Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
- (2016) Sebastian Palmqvist et al. BRAIN
- Regional profiles of the candidate tau PET ligand18F-AV-1451 recapitulate key features of Braak histopathological stages
- (2016) Adam J. Schwarz et al. BRAIN
- Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
- (2016) Rik Ossenkoppele et al. BRAIN
- In vivoimaging of neuromelanin in Parkinson’s disease using18F-AV-1451 PET
- (2016) Allan K. Hansen et al. BRAIN
- The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging
- (2016) Brian A. Gordon et al. BRAIN
- Tau imaging with [18F]THK-5351 in progressive supranuclear palsy
- (2016) A. Ishiki et al. EUROPEAN JOURNAL OF NEUROLOGY
- Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
- (2016) Konstantinos Chiotis et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer’s Disease
- (2016) Julian Dronse et al. JOURNAL OF ALZHEIMERS DISEASE
- Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner
- (2016) Juan Carlos Polanco et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Positron emission tomography imaging of tau pathology in progressive supranuclear palsy
- (2016) Sarah Coakeley et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
- (2016) Abbas M. Walji et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain
- (2016) J. Sepulcre et al. JOURNAL OF NEUROSCIENCE
- Reference Tissue–Based Kinetic Evaluation of 18 F-AV-1451 for Tau Imaging
- (2016) Suzanne L. Baker et al. JOURNAL OF NUCLEAR MEDICINE
- Tracer Kinetic Analysis of (S)-18F-THK5117 as a PET Tracer for Assessing Tau Pathology
- (2016) M. Jonasson et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
- (2016) E. D. Hostetler et al. JOURNAL OF NUCLEAR MEDICINE
- Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
- (2016) Richard S Finkel et al. LANCET
- 18F-AV-1451 binds to putamen in multiple system atrophy
- (2016) Hanna Cho et al. MOVEMENT DISORDERS
- [18F]AV-1451 tau positron emission tomography in progressive supranuclear palsy
- (2016) Jennifer L. Whitwell et al. MOVEMENT DISORDERS
- Subcortical18F-AV-1451 binding patterns in progressive supranuclear palsy
- (2016) Hanna Cho et al. MOVEMENT DISORDERS
- Increased basal ganglia binding of18F-AV-1451 in patients with progressive supranuclear palsy
- (2016) Ruben Smith et al. MOVEMENT DISORDERS
- Elevated in vivo [18F]-AV-1451 uptake in a patient with progressive supranuclear palsy
- (2016) Jochen Hammes et al. MOVEMENT DISORDERS
- Neuronal activity enhances tau propagation and tau pathology in vivo
- (2016) Jessica W Wu et al. NATURE NEUROSCIENCE
- Tau PET in Alzheimer disease and mild cognitive impairment
- (2016) Hanna Cho et al. NEUROLOGY
- In vivo visualization of tau deposits in corticobasal syndrome by 18 F-THK5351 PET
- (2016) Akio Kikuchi et al. NEUROLOGY
- Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly
- (2016) Jasmeer P. Chhatwal et al. NEUROLOGY
- PET Imaging of Tau Deposition in the Aging Human Brain
- (2016) Michael Schöll et al. NEURON
- Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F] THK-5351
- (2016) Samuel N. Lockhart et al. PLoS One
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer’s disease
- (2016) Laure Saint-Aubert et al. Alzheimers Research & Therapy
- Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease
- (2016) Francesco Panza et al. Biomed Research International
- Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy
- (2016) Liang Wang et al. JAMA Neurology
- Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases
- (2016) Stephen N. Gomperts et al. JAMA Neurology
- Cerebral [18 F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathy
- (2016) D L Dickstein et al. Translational Psychiatry
- Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease
- (2016) Gérard N. Bischof et al. Annals of Clinical and Translational Neurology
- An autoradiographic evaluation of AV-1451 Tau PET in dementia
- (2016) Val J. Lowe et al. Acta Neuropathologica Communications
- PART, a distinct tauopathy, different from classical sporadic Alzheimer disease
- (2015) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- PART is part of Alzheimer disease
- (2015) Charles Duyckaerts et al. ACTA NEUROPATHOLOGICA
- [ 18 F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β pathology
- (2015) Dietmar Rudolf Thal et al. Alzheimers & Dementia
- Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
- (2015) Marta Marquié et al. ANNALS OF NEUROLOGY
- Tau positron emission tomographic imaging in aging and early Alzheimer disease
- (2015) Keith A. Johnson et al. ANNALS OF NEUROLOGY
- Age and amyloid effects on human central nervous system amyloid-beta kinetics
- (2015) Bruce W. Patterson et al. ANNALS OF NEUROLOGY
- Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum
- (2015) Melissa E. Murray et al. BRAIN
- [18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease
- (2015) Ryuichi Harada et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease
- (2015) Rik Ossenkoppele et al. HUMAN BRAIN MAPPING
- Discovery and development of Seliciclib. How systems biology approaches can lead to better drug performance
- (2015) Hilal S. Khalil et al. JOURNAL OF BIOTECHNOLOGY
- 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
- (2015) R. Harada et al. JOURNAL OF NUCLEAR MEDICINE
- Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease
- (2015) T. Tago et al. JOURNAL OF NUCLEAR MEDICINE
- The history and future of targeting cyclin-dependent kinases in cancer therapy
- (2015) Uzma Asghar et al. NATURE REVIEWS DRUG DISCOVERY
- Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
- (2015) Sebastian Palmqvist et al. NEUROLOGY
- Identification of a major radiometabolite of [ 11 C]PBB3
- (2015) Hiroki Hashimoto et al. NUCLEAR MEDICINE AND BIOLOGY
- Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue
- (2015) Laetitia Lemoine et al. Acta Neuropathologica Communications
- Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [18F]THK-5117 Positron Emission Tomography
- (2015) Aiko Ishiki et al. PLoS One
- High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer’s Disease and Progressive Supranuclear Palsy: Synthesis, Preclinical Evaluation, and Lead Selection
- (2014) Maria V. Fawaz et al. ACS Chemical Neuroscience
- A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity
- (2014) Zeshan Ahmed et al. ACTA NEUROPATHOLOGICA
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- PART and SNAP
- (2014) Clifford R. Jack ACTA NEUROPATHOLOGICA
- In vivo tau imaging: Obstacles and progress
- (2014) Victor L. Villemagne et al. Alzheimers & Dementia
- Tau, amyloid, and hypometabolism in a patient with posterior cortical atrophy
- (2014) Rik Ossenkoppele et al. ANNALS OF NEUROLOGY
- Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
- (2014) Niklas Mattsson et al. BRAIN
- Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
- (2014) David R. Howlett et al. BRAIN PATHOLOGY
- In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease
- (2014) Victor L. Villemagne et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology
- (2014) H. Hashimoto et al. JOURNAL OF NUCLEAR MEDICINE
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials
- (2014) Reisa Sperling et al. NEURON
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- Diagnostic Performance of Cerebrospinal Fluid Total Tau and Phosphorylated Tau in Creutzfeldt-Jakob Disease
- (2014) Tobias Skillbäck et al. JAMA Neurology
- Tauopathy PET and amyloid PET in the diagnosis of chronic traumatic encephalopathies: studies of a retired NFL player and of a man with FTD and a severe head injury
- (2014) E M Mitsis et al. Translational Psychiatry
- Amyloid or tau: the chicken or the egg?
- (2013) David M. A. Mann et al. ACTA NEUROPATHOLOGICA
- Reply: the early pathological process in sporadic Alzheimer’s disease
- (2013) Heiko Braak et al. ACTA NEUROPATHOLOGICA
- Amyloid and tau: neither chicken nor egg but two partners in crime!
- (2013) Johannes Attems et al. ACTA NEUROPATHOLOGICA
- [18F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
- (2013) Chun-Fang Xia et al. Alzheimers & Dementia
- Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid
- (2013) Susan M. Landau et al. ANNALS OF NEUROLOGY
- Distinct α-Synuclein Strains Differentially Promote Tau Inclusions in Neurons
- (2013) Jing L. Guo et al. CELL
- Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease
- (2013) N. Okamura et al. JOURNAL OF NUCLEAR MEDICINE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
- (2013) Mathias Jucker et al. NATURE
- Criteria for the diagnosis of corticobasal degeneration
- (2013) M. J. Armstrong et al. NEUROLOGY
- Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls
- (2013) Masahiro Maruyama et al. NEURON
- Biomarker Modeling of Alzheimer’s Disease
- (2013) Clifford R. Jack et al. NEURON
- Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
- (2013) Jere E. Meredith Jr. et al. PLoS One
- Effect of Complement CR1 on Brain Amyloid Burden During Aging and Its Modification by APOE Genotype
- (2012) Madhav Thambisetty et al. BIOLOGICAL PSYCHIATRY
- The spectrum of disease in chronic traumatic encephalopathy
- (2012) Ann C. McKee et al. BRAIN
- Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
- (2012) Peter T. Nelson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
- (2012) Alix de Calignon et al. NEURON
- Tau pathology in children and young adults: can you still be unconditionally baptist?
- (2011) Charles Duyckaerts ACTA NEUROPATHOLOGICA
- Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Clifford R. Jack et al. Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome
- (2011) Naomi Kouri et al. BRAIN
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Post-translational modifications of tau protein: Implications for Alzheimer's disease
- (2011) Ludovic Martin et al. NEUROCHEMISTRY INTERNATIONAL
- Molecular imaging in Alzheimer's disease: new perspectives on biomarkers for early diagnosis and drug development
- (2011) Agneta Nordberg Alzheimers Research & Therapy
- Characterization of tau fibrillization in vitro
- (2010) Shaohua Xu et al. Alzheimers & Dementia
- Synergistic Interactions between A , Tau, and -Synuclein: Acceleration of Neuropathology and Cognitive Decline
- (2010) L. K. Clinton et al. JOURNAL OF NEUROSCIENCE
- Cognition, glucose metabolism and amyloid burden in Alzheimer's disease
- (2010) Ansgar J. Furst et al. NEUROBIOLOGY OF AGING
- Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies
- (2009) Paul W. Thompson et al. JOURNAL OF NEUROCHEMISTRY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
- (2008) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
- Tau exon 10 alternative splicing and tauopathies
- (2008) Fei Liu et al. Molecular Neurodegeneration
- Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease
- (2008) Meredith N. Braskie et al. NEUROBIOLOGY OF AGING
- Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
- (2008) Scott A. Small et al. NEURON
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started